{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:10:56Z","timestamp":1790392256694,"version":"4.1.0"},"reference-count":38,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Real-time continuous glucose monitoring (RT-CGM) provides information on glycemic variability (GV), time in range (TIR), and guidance to avoid hypoglycemia, thereby complimenting HbA1c for diabetes management. We investigated whether GV and TIR were independently associated with chronic and acute diabetes complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between September 2014 and January 2017, 515 subjects with type 1 diabetes using sensor-augmented pump therapy were followed for 24 months. The link between baseline HbA1c and CGM-derived glucometrics (TIR [70-180 mg\/dL], coefficient of variation [CV], and SD) obtained from the first 2 weeks of RT-CGM use and the presence of complications was investigated. Complications were defined as: composite microvascular complications (presence of neuropathy, retinopathy, or nephropathy), macrovascular complications, and hospitalization for hypoglycemia and\/or ketoacidosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Individuals with microvascular complications were older (P &amp;lt; 0.001), had a longer diabetes duration (P &amp;lt; 0.001), a higher HbA1c (7.8 \u00b1 0.9 vs 7.5 \u00b1 0.9%, P &amp;lt; 0.001), and spent less time in range (60.4 \u00b1 12.2 vs 63.9 \u00b1 13.8%, P = 0.022) compared with those without microvascular complication. Diabetes duration (odds ratio [OR] = 1.12 [1.09-1.15], P &amp;lt; 0.001) and TIR (OR = 0.97 [0.95-0.99], P = 0.005) were independent risk factors for composite microvascular complications, whereas SD and CV were not. Age (OR = 1.08 [1.03-1.14], P = 0.003) and HbA1c (OR = 1.80 [1.02-3.14], P = 0.044) were risk factors for macrovascular complications. TIR (OR = 0.97 [0.95-0.99], P = 0.021) was the only independent risk factor for hospitalizations for hypoglycemia or ketoacidosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Lower TIR was associated with the presence of composite microvascular complications and with hospitalization for hypoglycemia or ketoacidosis. TIR, SD, and CV were not associated with macrovascular complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgab688","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T14:40:23Z","timestamp":1631889623000},"page":"e570-e581","source":"Crossref","is-referenced-by-count":108,"title":["Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes Mellitus"],"prefix":"10.1210","volume":"107","author":[{"given":"Anass","family":"El Malahi","sequence":"first","affiliation":[{"name":"Endocrinology-Diabetology, University Hospital Antwerp, 2650 Edegem, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Van Elsen","sequence":"additional","affiliation":[{"name":"Endocrinology-Diabetology, University Hospital Antwerp, 2650 Edegem, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2100-4927","authenticated-orcid":false,"given":"Sara","family":"Charleer","sequence":"additional","affiliation":[{"name":"Endocrinology, University Hospitals Leuven - KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5211-2210","authenticated-orcid":false,"given":"Eveline","family":"Dirinck","sequence":"additional","affiliation":[{"name":"Endocrinology-Diabetology, University Hospital Antwerp, 2650 Edegem, Belgium"},{"name":"Laboratorium of Experimental Medicine and Pediatrics and member of the Infla-Med Centre of Excellence, University of Antwerp, Faculty of Medicine & Health Sciences, 2610 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4377-7648","authenticated-orcid":false,"given":"Kristien","family":"Ledeganck","sequence":"additional","affiliation":[{"name":"Laboratorium of Experimental Medicine and Pediatrics and member of the Infla-Med Centre of Excellence, University of Antwerp, Faculty of Medicine & Health Sciences, 2610 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8671-4527","authenticated-orcid":false,"given":"Bart","family":"Keymeulen","sequence":"additional","affiliation":[{"name":"Diabetology, University Hospital Brussels, 1090 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2326-4108","authenticated-orcid":false,"given":"Laurent","family":"Crenier","sequence":"additional","affiliation":[{"name":"Endocrinology, Universit\u00e9 Libre de Bruxelles \u2013 H\u00f4pital Erasme, 1070 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2866-8171","authenticated-orcid":false,"given":"R\u00e9gis","family":"Radermecker","sequence":"additional","affiliation":[{"name":"Diabetes, Nutrition and Metabolic disorders, CHU Li\u00e8ge, Clinical Pharmacology, Li\u00e8ge University, 4000 Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youri","family":"Taes","sequence":"additional","affiliation":[{"name":"Endocrinology, AZ Sint-Jan Brugge, 8000 Bruges, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Vercammen","sequence":"additional","affiliation":[{"name":"Endocrinology, Imelda Hospital, 2820 Bonheiden, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Nobels","sequence":"additional","affiliation":[{"name":"Endocrinology, OLV Hospital Aalst, 9300 Aalst, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4055-5233","authenticated-orcid":false,"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[{"name":"Endocrinology, University Hospitals Leuven - KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9111-4561","authenticated-orcid":false,"given":"Pieter","family":"Gillard","sequence":"additional","affiliation":[{"name":"Endocrinology, University Hospitals Leuven - KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0679-3203","authenticated-orcid":false,"given":"Christophe","family":"De Block","sequence":"additional","affiliation":[{"name":"Endocrinology-Diabetology, University Hospital Antwerp, 2650 Edegem, Belgium"},{"name":"Laboratorium of Experimental Medicine and Pediatrics and member of the Infla-Med Centre of Excellence, University of Antwerp, Faculty of Medicine & Health Sciences, 2610 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"issue":"25","key":"2022011806204266900_CIT0001","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med."},{"issue":"4","key":"2022011806204266900_CIT0002","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1002853","article-title":"Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes","volume":"363","author":"Bergenstal","year":"2010","journal-title":"N Engl J Med."},{"issue":"10128","key":"2022011806204266900_CIT0003","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(18)30297-6","article-title":"Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial","volume":"391","author":"Heinemann","year":"2018","journal-title":"Lancet."},{"issue":"11","key":"2022011806204266900_CIT0004","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S2213-8587(16)30193-0","article-title":"Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial","volume":"4","author":"van Beers","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"2022011806204266900_CIT0005","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-8587(19)30150-0","article-title":"Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial","volume":"7","author":"Bosi","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"2022011806204266900_CIT0006","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2337\/dc19-0888","article-title":"Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study","volume":"43","author":"\u0160oupal","year":"2020","journal-title":"Diabetes Care."},{"issue":"3","key":"2022011806204266900_CIT0007","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1210\/jc.2017-02498","article-title":"Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study","volume":"103","author":"Charleer","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022011806204266900_CIT0008","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.2337\/dc20-1531","article-title":"Sustained impact of real-time continuous glucose monitoring in adults with type 1 diabetes on insulin pump therapy: results after the 24-month RESCUE study","volume":"43","author":"Charleer","year":"2020","journal-title":"Diabetes Care."},{"issue":"5","key":"2022011806204266900_CIT0009","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2337\/dc19-1459","article-title":"Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials","volume":"43","author":"Maiorino","year":"2020","journal-title":"Diabetes Care."},{"key":"2022011806204266900_CIT0010","first-page":"2042018819871903","article-title":"The road from intermittently scanned continuous glucose monitoring to hybrid closed-loop systems. Part B: results from randomized controlled trials","volume":"10","author":"De Ridder","year":"2019","journal-title":"Ther Adv Endocrinol Metab."},{"issue":"8","key":"2022011806204266900_CIT0011","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/dc17-0636","article-title":"The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading","volume":"40","author":"Beck","year":"2017","journal-title":"Diabetes Care."},{"issue":"8","key":"2022011806204266900_CIT0012","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care."},{"issue":"4","key":"2022011806204266900_CIT0013","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/1932296818822496","article-title":"The relationships between time in range, hyperglycemia metrics, and HbA1c","volume":"13","author":"Beck","year":"2019","journal-title":"J Diabetes Sci Technol."},{"issue":"11","key":"2022011806204266900_CIT0014","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2337\/dc08-0864","article-title":"A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial","volume":"31","author":"Kilpatrick","year":"2008","journal-title":"Diabetes Care."},{"issue":"9","key":"2022011806204266900_CIT0015","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1210\/jc.2015-3604","article-title":"Association between HbA1c variability and risk of microvascular complications in adolescents with type 1 diabetes","volume":"101","author":"Virk","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022011806204266900_CIT0016","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.2337\/dc15-1188","article-title":"Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis","volume":"38","author":"Gorst","year":"2015","journal-title":"Diabetes Care."},{"issue":"3","key":"2022011806204266900_CIT0017","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.diabres.2014.06.007","article-title":"Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes","volume":"105","author":"Smith-Palmer","year":"2014","journal-title":"Diabetes Res Clin Pract."},{"issue":"3","key":"2022011806204266900_CIT0018","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00592-013-0459-9","article-title":"Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes","volume":"50","author":"Sartore","year":"2013","journal-title":"Acta Diabetol."},{"issue":"5","key":"2022011806204266900_CIT0019","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00592-017-0971-4","article-title":"Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability","volume":"54","author":"Picconi","year":"2017","journal-title":"Acta Diabetol."},{"issue":"4","key":"2022011806204266900_CIT0020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/dia.2013.0205","article-title":"Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control","volume":"16","author":"\u0160oupal","year":"2014","journal-title":"Diabetes Technol Ther."},{"issue":"7","key":"2022011806204266900_CIT0021","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2337\/dc06-0293","article-title":"The effect of glucose variability on the risk of microvascular complications in type 1 diabetes","volume":"29","author":"Kilpatrick","year":"2006","journal-title":"Diabetes Care."},{"issue":"10","key":"2022011806204266900_CIT0022","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2337\/dc09-0109","article-title":"Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes","volume":"32","author":"Kilpatrick","year":"2009","journal-title":"Diabetes Care."},{"issue":"6","key":"2022011806204266900_CIT0023","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/eye.2016.48","article-title":"Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus","volume":"30","author":"Stem","year":"2016","journal-title":"Eye (Lond)."},{"issue":"6","key":"2022011806204266900_CIT0024","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/dia.2011.0229","article-title":"Hypoglycemia, but not glucose variability, relates to vascular function in children with type 1 diabetes","volume":"14","author":"Pe\u00f1a","year":"2012","journal-title":"Diabetes Technol Ther."},{"issue":"3","key":"2022011806204266900_CIT0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jdiacomp.2004.10.001","article-title":"Should minimal blood glucose variability become the gold standard of glycemic control?","volume":"19","author":"Hirsch","year":"2005","journal-title":"J Diabetes Complications."},{"issue":"3","key":"2022011806204266900_CIT0026","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck","year":"2019","journal-title":"Diabetes Care."},{"issue":"10","key":"2022011806204266900_CIT0027","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1089\/dia.2019.0499","article-title":"Association between continuous glucose monitoring-derived time in range, other core metrics, and albuminuria in type 2 diabetes","volume":"22","author":"Yoo","year":"2020","journal-title":"Diabetes Technol Ther."},{"issue":"11","key":"2022011806204266900_CIT0028","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2337\/dc18-1131","article-title":"Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes","volume":"41","author":"Lu","year":"2018","journal-title":"Diabetes Care."},{"issue":"10","key":"2022011806204266900_CIT0029","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2337\/dc20-0016","article-title":"The relationship between CGM-derived metrics, A1C, and risk of hypoglycemia in older adults with type 1 diabetes","volume":"43","author":"Toschi","year":"2020","journal-title":"Diabetes Care."},{"key":"2022011806204266900_CIT0030","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/bmjdrc-2019-000991","article-title":"Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease","volume":"8","author":"Mayeda","year":"2020","journal-title":"BMJ Open Diab Res Care"},{"issue":"11","key":"2022011806204266900_CIT0031","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.2337\/dc20-0909","article-title":"Improved time in range over 1 year is associated with reduced albuminuria in individuals with sensor-augmented insulin pump-treated type 1 diabetes","volume":"43","author":"Ranjan","year":"2020","journal-title":"Diabetes Care."},{"issue":"8","key":"2022011806204266900_CIT0032","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.2337\/dc20-0561","article-title":"Comparison of multiple cut points for time in range in relation to risk of abnormal carotid intima-media thickness and diabetic retinopathy","volume":"43","author":"Lu","year":"2020","journal-title":"Diabetes Care."},{"issue":"2","key":"2022011806204266900_CIT0033","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/dc20-1862","article-title":"Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study","volume":"44","author":"Lu","year":"2021","journal-title":"Diabetes Care."},{"key":"2022011806204266900_CIT0034","doi-asserted-by":"crossref","first-page":"108289","DOI":"10.1016\/j.diabres.2020.108289","article-title":"TIR generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes","volume":"166","author":"Li","year":"2020","journal-title":"Diabetes Res Clin Pract."},{"issue":"7","key":"2022011806204266900_CIT0035","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/dc16-1769","article-title":"Toward defining the threshold between low and high glucose variability in diabetes","volume":"40","author":"Monnier","year":"2017","journal-title":"Diabetes Care."},{"issue":"12","key":"2022011806204266900_CIT0036","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International Consensus on Use of Continuous Glucose Monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care."},{"issue":"3","key":"2022011806204266900_CIT0037","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","article-title":"Glycaemic variability in diabetes: clinical and therapeutic implications","volume":"7","author":"Ceriello","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"2022011806204266900_CIT0038","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11892-018-0979-3","article-title":"Diabetic kidney disease: is there a role for glycemic variability?","volume":"18","author":"Subramanian","year":"2018","journal-title":"Curr Diab Rep."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab688\/40533725\/dgab688.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/2\/e570\/42224589\/dgab688.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/2\/e570\/42224589\/dgab688.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T01:22:15Z","timestamp":1642468935000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/2\/e570\/6371790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,9,17]]},"published-print":{"date-parts":[[2022,1,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab688","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,9,17]]}}}